1. Elucidation of parameters other than age that define the AYA patient 2. Development of and participation in clinical trials benefiting AYA patients 3. Specialization of health services delivery 4….
Fig. 6.1 Incidence of acute myelogenous leukemia (AML) by sex and single years of age in children and AYAs (Surveillance, Epidemiology, and End Results, US SEER 18 regions, 2000–2011) Incidence…
Fig. 29.1 Multiple factors contribute to cancer-related morbidity The risks of late effects may be modified, either positively or negatively, by host (gender, age, race, genetics), cancer (location, histology, biology),…
Fig. 21.1 Numbers of patients recruited to US cancer trials by 5-year intervals (Personal communication with author) Fig. 21.2 Number of children, teenagers and young adults with newly diagnosed cancer…
References 1. Albritton K, Barr R, Bleyer A (2009) The adolescence of young adult oncology. Semin Oncol 36(5):478–488CrossRef 2. Vance R (2004) The marriage of cancer control and advocacy. CA…
Fig. 13.1 Incidence of invasive and in situ malignancy of the colorectum (adenocarcinoma) and the anal canal (squamous cell carcinoma), United States, SEER 2000–2011. In AYAs (inset) incidence increases exponentially…
Fig. 22.1 Conceptual framework for understandig barriers to adherence (McCue et al. [9] with permission) It is important to recognize that adherence is dynamic and must be viewed not only…
Fig. 30.1 Number of publications per year from January 1994 to December 2013 30.1.3 Patient-Reported Outcome Instruments HRQL is typically measured using Clinical Outcome Assessment (COA) tools, i.e., instruments designed…
Type of sexual difficulty Men 16–24 years Men 25–34 years Women 16–24 years Women 25–34 years Lacked interest in having sex 11.5 % 14.5 % 24.8 % 31.9 % Lacked…
Fig. 16.1 Proportion of major bone sarcoma groups by age (SEER, 2000–2011) Fig. 16.2 Bone incidence by type and age from SEER (2000–2011) The clinical significance of bone sarcomas in…
